The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission'.
Two vaccines, namely Covishield manufactured by the Serum Institute of India and Covaxin manufactured by Bharat Biotech, that have been granted permission for restricted use in emergency situation by the national regulator are being procured by the central government for free supply to states/UTs.
In August, Pfizer plans to ask the Food and Drug Administration for emergency authorization of a third dose.
"The company has received permission from Drugs Controller General of India (DCGI) to import Moderna's COVID-19 vaccine for restricted emergency use in the country."
A total of 30,16,26,028 vaccine doses have been administered through 40,45,516 sessions, as per the provisional report on Thursday, with 64,89,599 vaccine doses administered in the last 24 hours.
Of the 80 low-income countries involved in Covax, "at least half of them do not have sufficient vaccines to be able to sustain their programmes right now", Aylward said, at a WHO briefing in Geneva on Monday.
The White House on Monday introduced plans to share 55 million Covid-19 vaccine doses with the rest of the world.
The two-dose Covid shot will be available at Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Mohali. It will be extended at more Fortis hospitals across 11 cities. The price per dose for Sputnik V (as fixed by the government) including administrative charges is Rs 1,145.
Novavax Inc had announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall.
"Sonu Sood had received the drugs from several pharmacies located inside the private Lifeline Care Hospital in Goregaon. Pharma company Cipla had supplied Remdesivir to these pharmacies and inquiry into it was still going on," Kumbhakoni said.
On the decision to increase the gap between two doses of Covishield from four-six weeks to 12-16 weeks, he said the move was based on scientific decision and there was no dissenting voice among the National Technical Advisory Group on Immunisation (NTAGI) members.
Speaking at the end of a G-7 leaders' summit in southwest England, British Prime Minister Boris Johnson praised the fantastic degree of harmony among the reenergised group, which met in person for the first time in two years.
Noting that 60 per cent to 70 per cent of the children who got infected and got admitted in hospitals during the second wave in India, had either comorbidities or low immunity, the All India Institute of Medical Sciences (AIIMS) Director said that healthy children recovered with mild illness without need for hospitalisation.
Vaccine doses provided free of cost by the Centre will be allocated to states and union territories based on criteria such as population, disease burden and progress of vaccination.
India has to stretch its finances even in FY21 as Covid pandemic and nationwide lockdown severely dented economic environment pushing up India's deficit with lower revenue and higher expenditure.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.